SEARCH RESULTS for assignor:"GUPTA, ASHOK K."

Showing 1 to 4 of 4 results

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
11-May-2018

(X0) 1: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

(A1) 2: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

COGSWELL, JOHN P.

GOLDBERG, STACIE M.

GUPTA, ASHOK K.

JURE-KUNKEL, MARIA

WANG, XI-TAO

WIGGINTON, JON M.

BRISTOL-MYERS SQUIBB COMPANY

45762/37

03-May-2018

(X0) 1: COMBINATION OF ANTI-KIR AND ANTI-CTLA-4 ANTIBODIES TO TREAT CANCER

(A1) 2: COMBINATION OF ANTI-KIR AND ANTI-CTLA-4 ANTIBODIES TO TREAT CANCER

GRAZIANO, ROBERT F.

GUPTA, ASHOK K.

KIM, SU YOUNG

WIGGINTON, JON

BRISTOL-MEYERS SQUIBB COMPANY

43922/939

12-Apr-2018

(X0) 1: COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER

(A1) 2: COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER

GRAZIANO, ROBERT F.

GUPTA, ASHOK K.

KIM, SU YOUNG

WIGGINTON, JON

BRISTOL-MEYERS SQUIBB COMPANY

43922/111

02-Jan-2018

(X0) 1: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

(B1) 9: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

COGSWELL, JOHN P.

GOLDBERG, STACIE M.

GUPTA, ASHOK K.

JURE-KUNKEL, MARIA

WANG, XI TAO

WIGGINTON, JON M.

BRISTOL-MYERS SQUIBB COMPANY

30969/556